Please check your internet connection and try again.
# Sompraz HP
## Overview
Sompraz HP is a combination product containing pantoprazole, amoxicillin, and clarithromycin, used for the eradication of *Helicobacter pylori* infection.
## Primary Indications
Treatment of *Helicobacter pylori* infection in patients with peptic ulcer disease.
## Adult Dosing
**Sompraz HP:** Each blister pack contains:
* Pantoprazole 40 mg delayed-release tablet
* Amoxicillin 500 mg capsule
* Clarithromycin 500 mg tablet
Take one blister pack twice daily (morning and evening) for 7 to 14 days. For best results, take 30 minutes before a meal.
## Pediatric Dosing
The use of Sompraz HP in pediatric patients is not established. Dosing for individual components (pantoprazole, amoxicillin, clarithromycin) in pediatric patients would require separate consideration based on age, weight, and renal/hepatic function according to pediatric guidelines.
## Dose Adjustments
* **Renal Impairment:** No dose adjustment is typically required for pantoprazole, amoxicillin, or clarithromycin in mild to moderate renal impairment. In severe renal impairment, caution and dose adjustment may be necessary for amoxicillin and clarithromycin; specific recommendations should be sought.
* **Hepatic Impairment:** No dose adjustment is typically required for amoxicillin. In moderate to severe hepatic impairment, caution is advised for pantoprazole. Clarithromycin dose adjustment may be necessary in severe hepatic impairment.
## Contraindications
* Known hypersensitivity to pantoprazole, amoxicillin, clarithromycin, other macrolides, or penicillins.
* History of cholestatic jaundice/hepatic dysfunction associated with prior clarithromycin use.
* Concomitant use with rifabutin, cisapride, ergot alkaloids, midazolam, or pimozide (due to clarithromycin).
## Adverse Effects
Common adverse effects include diarrhea, nausea, abdominal pain, vomiting, rash, headache, dysgeusia (altered taste), and elevated liver enzymes. Serious adverse effects can include severe allergic reactions (including anaphylaxis), *Clostridioides difficile*-associated diarrhea, QT prolongation (especially with clarithromycin), and hepatotoxicity.
## Key Drug Interactions
* **Clarithromycin:** Potent CYP3A4 inhibitor. Interactions with numerous drugs including statins, warfarin, anticonvulsants, benzodiazepines, and anticoagulants.
* **Pantoprazole:** Can decrease absorption of drugs requiring acidic environments (e.g., ketoconazole, itraconazole, certain HIV protease inhibitors). May affect the metabolism of other drugs via CYP enzymes, though less significantly than clarithromycin.
* **Amoxicillin:** May decrease the efficacy of oral contraceptives.
## Monitoring
* Monitor for signs and symptoms of hypersensitivity reactions.
* Assess for diarrhea, particularly *Clostridioides difficile*-associated diarrhea.
* Monitor liver function tests, especially with prolonged use or in patients with hepatic impairment.
* Evaluate for signs of QT prolongation, particularly in patients with risk factors.
## Clinical Pearls
* Ensure patient is not allergic to penicillins or macrolides before initiation.
* Administer the full course of therapy as prescribed, even if symptoms improve.
* Advise patients to report any severe or persistent diarrhea, rash, or signs of liver problems immediately.
* Consider *H. pylori* testing after treatment completion to confirm eradication.
***
*Disclaimer: This information is intended for healthcare professionals and is not a substitute for professional medical advice. Always consult the most current prescribing information and relevant clinical guidelines before making any treatment decisions.*
